Unique ID issued by UMIN | UMIN000032997 |
---|---|
Receipt number | R000037597 |
Scientific Title | Exploratory test to investigate the clinical pregnancy rate between four vaginal progesterones:Lutinus vaginal tablet(300 mg/day), Utrogestan Vaginal Capsule(600 mg/day), Luteum Vaginal Suppository(800 mg/day), Crinone vaginal gel (90 mg/day) |
Date of disclosure of the study information | 2018/06/14 |
Last modified on | 2019/03/03 17:33:44 |
Exploratory test to investigate the clinical pregnancy rate between four vaginal progesterones:Lutinus vaginal tablet(300 mg/day), Utrogestan Vaginal Capsule(600 mg/day), Luteum Vaginal Suppository(800 mg/day), Crinone vaginal gel (90 mg/day)
EXCULL-STUDY
Exploratory test to investigate the clinical pregnancy rate between four vaginal progesterones:Lutinus vaginal tablet(300 mg/day), Utrogestan Vaginal Capsule(600 mg/day), Luteum Vaginal Suppository(800 mg/day), Crinone vaginal gel (90 mg/day)
EXCULL-STUDY
Japan |
infertility
Obstetrics and Gynecology |
Others
NO
To investigate the efficacy of four vaginal progesterones as luteal phase support (LPS) in Frozen-thawed Embryo Transfer (Frozen-ET) cycles, including Lutinus, Utrogestan, Luteum, Crinone.
Others
To assess the relationship between serum progesteon level and clinical pregnancy rate of four vaginal progesterones
Exploratory
Not applicable
Clinical pregnancy rate (CPR), Fetal heartbeat positive rate(FHR) and miscarriage rate (MR).
serum progesterone
Interventional
Parallel
Randomized
Cluster
Open -no one is blinded
Active
4
Treatment
Medicine |
Lutinus (3 doses of 100 mg per day)
Utrogestan (3 doses of 200 mg per day)
Luteum (2 doses of 400 mg per day)
Onecrinone (1 dose of 90 mg per day)
20 | years-old | <= |
50 | years-old | > |
Female
1) Patients who will undergo the frozen embryo transfer in hormone replacement therapy cycles.
2) Patients who have given written informed consent to participate in this study
Patients related to the contraindication items described in the drug package
240
1st name | |
Middle name | |
Last name | REIKO SHIBA |
Kinutani Womens Clinic
doctor department
4F 8-23 Hondori, Naka-ku, Hiroshima-city, Hiroshima-Prefecture
082-247-6399
reiko.shiba0703@gmail.com
1st name | |
Middle name | |
Last name | REIKO SHIBA |
Kinutani Womens Clinic
Doctor department
4F 8-23 Hondori, Naka-ku, Hiroshima-city, Hiroshima-Prefecture
082-247-6399
reiko.shiba0703@gmail.com
Kinutani Womens Clinic
Kinutani Womens Clinic
Self funding
NO
2018 | Year | 06 | Month | 14 | Day |
Unpublished
Completed
2016 | Year | 11 | Month | 01 | Day |
2016 | Year | 12 | Month | 01 | Day |
2017 | Year | 12 | Month | 30 | Day |
2018 | Year | 06 | Month | 14 | Day |
2019 | Year | 03 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037597
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |